{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:06:40Z","timestamp":1786982800211,"version":"build-2736575974"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T00:00:00Z","timestamp":1711411200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T00:00:00Z","timestamp":1711411200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100005416","name":"Norges Forskningsr\u00e5d","doi-asserted-by":"publisher","award":["273563"],"award-info":[{"award-number":["273563"]}],"id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005029","name":"Helse Vest Regionalt Helsef\u00f8retak","doi-asserted-by":"publisher","award":["F-12150"],"award-info":[{"award-number":["F-12150"]}],"id":[{"id":"10.13039\/501100005029","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006095","name":"Helse S\u00f8r-\u00d8st RHF","doi-asserted-by":"publisher","award":["2017014"],"award-info":[{"award-number":["2017014"]}],"id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]},{"name":"University of Bergen"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["High Blood Press Cardiovasc Prev"],"DOI":"10.1007\/s40292-024-00632-6","type":"journal-article","created":{"date-parts":[[2024,3,26]],"date-time":"2024-03-26T08:02:30Z","timestamp":1711440150000},"page":"157-166","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Gender Differences in Cardiac Organ Damage in Arterial Hypertension: Assessing the Role of Drug Nonadherence"],"prefix":"10.1007","volume":"31","clinical-trial-number":[{"clinical-trial-number":"nct03209154","registry":"10.18810\/clinical-trials-gov"}],"author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6363-9819","authenticated-orcid":false,"given":"Arleen","family":"Aune","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annabel","family":"Ohldieck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lene V.","family":"Halvorsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl Marius","family":"Brobak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eirik","family":"Olsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stine","family":"Rognstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne Cecilie K.","family":"Larstorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla L.","family":"S\u00f8raas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne B.","family":"Rosseb\u00f8","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Assami","family":"R\u00f6sner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne Aa.","family":"Grytaas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Gerdts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,3,26]]},"reference":[{"key":"632_CR1","doi-asserted-by":"crossref","unstructured":"Mancia G, Kreutz R, Brunstr\u00f6m M, Burnier M, Grassi G, Januszewicz A, Muiesan ML, Tsioufis K, Agabiti-Rosei E, Algharably EAE, Azizi M, Benetos A, Borghi C, Hitij JB, Cifkova R, Coca A, Cornelissen V, Cruickshank K, Cunha PG, Danser AHJ, Pinho RM de, Delles C, Dominiczak AF, Dorobantu M, Doumas M, Fern\u00e1ndez-Alfonso MS, Halimi JM, J\u00e1rai Z, Jelakovi\u0107 B, Jordan J, Kuznetsova T, Laurent S, Lovic D, Lurbe E, Mahfoud F, Manolis A, Miglinas M, Narkiewicz K, Niiranen T, Palatini P, Parati G, Pathak A, Persu A, Polonia J, Redon J, Sarafidis P, Schmieder R, Spronck B, Stabouli S, Stergiou G, Taddei S, Thomopoulos C, Tomaszewski M, Borne PV de, Wanner C, Weber T, Williams B, Zhang ZY, Kjeldsen SE, Members: AF. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension Endorsed by the European Renal Association (ERA) and the International Society of Hypertension (ISH). J Hypertens. 2023;10\u20131097.","DOI":"10.1097\/HJH.0000000000003480"},{"issue":"6","key":"632_CR2","doi-asserted-by":"publisher","first-page":"1113","DOI":"10.1161\/HYPERTENSIONAHA.116.08729","volume":"69","author":"P Gupta","year":"2017","unstructured":"Gupta P, Patel P, \u0160trauch B, Lai FY, Akbarov A, Mare\u0161ov\u00e1 V, White CMJ, Petr\u00e1k O, Gulsin GS, Patel V, Rosa J, Cole R, Zelinka T, Holaj R, Kinnell A, Smith PR, Thompson JR, Squire I, Widimsk\u00fd J, Samani NJ, Williams B, Tomaszewski M. Risk factors for nonadherence to antihypertensive treatment. Hypertension. 2017;69(6):1113\u201320.","journal-title":"Hypertension"},{"key":"632_CR3","doi-asserted-by":"crossref","unstructured":"Leung AA, Williams JVA, McAlister FA, Campbell NRC, Padwal RS, Committee HCR and E, Tran K, Tsuyuki R, McAlister FA, Campbell NRC, Khan N, Padwal R, Quan H, Leung AA. Worsening hypertension awareness, treatment, and control rates in canadian women between 2007 and 2017. Can J Cardiol. 2020;36(5):732\u20139.","DOI":"10.1016\/j.cjca.2020.02.092"},{"issue":"2","key":"632_CR4","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1007\/s40292-018-0257-0","volume":"25","author":"E Lodi","year":"2018","unstructured":"Lodi E, Carollo A, Martinotti V, Modena MG. Hypertension and pharmacological therapy in women. High Blood Press Cardiovasc Prev. 2018;25(2):147\u201350.","journal-title":"High Blood Press Cardiovasc Prev."},{"issue":"4","key":"632_CR5","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1111\/jgs.12171","volume":"61","author":"E Holt","year":"2013","unstructured":"Holt E, Joyce C, Dornelles A, Morisky D, Webber LS, Muntner P, Krousel-Wood M. Sex differences in barriers to antihypertensive medication adherence: findings from the cohort study of medication adherence among older adults. J Am Geriatr Soc. 2013;61(4):558\u201364.","journal-title":"J Am Geriatr Soc"},{"issue":"6","key":"632_CR6","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1097\/HJH.0000000000002398","volume":"38","author":"AJ Lawson","year":"2020","unstructured":"Lawson AJ, Hameed MA, Brown R, Cappuccio FP, George S, Hinton T, Kapil V, Lenart J, Lobo MD, Martin U, Menon M, Nightingale A, Rylance PB, Webb DJ, Dasgupta I. Nonadherence to antihypertensive medications is related to pill burden in apparent treatment-resistant hypertensive individuals. J Hypertens. 2020;38(6):1165\u201373.","journal-title":"J Hypertens"},{"key":"632_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajpc.2021.100230","volume":"8","author":"N Osude","year":"2021","unstructured":"Osude N, Durazo-Arvizu R, Markossian T, Liu K, Michos ED, Rakotz M, Wozniak G, Egan B, Kramer H. Age and sex disparities in hypertension control: the multi-ethnic study of atherosclerosis (MESA). Am J Prev Cardiol. 2021;8: 100230.","journal-title":"Am J Prev Cardiol."},{"issue":"17","key":"632_CR8","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.122.026582","volume":"11","author":"EKP Lee","year":"2022","unstructured":"Lee EKP, Poon P, Yip BHK, Bo Y, Zhu M, Yu C, Ngai ACH, Wong MCS, Wong SYS. Global burden, regional differences, trends, and health consequences of medication nonadherence for hypertension during 2010 to 2020: a meta-analysis involving 27 million patients. J Am Heart Assoc. 2022;11(17): e026582.","journal-title":"J Am Heart Assoc"},{"issue":"Pt B","key":"632_CR9","doi-asserted-by":"publisher","first-page":"142","DOI":"10.1016\/j.phrs.2017.08.015","volume":"125","author":"M Burnier","year":"2017","unstructured":"Burnier M. Drug adherence in hypertension. Pharmacol Res. 2017;125(Pt B):142\u20139.","journal-title":"Pharmacol Res"},{"issue":"2","key":"632_CR10","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1161\/01.HYP.0000254322.96189.85","volume":"49","author":"E Gerdts","year":"2007","unstructured":"Gerdts E, Wachtell K, Omvik P, Otterstad JE, Oikarinen L, Boman K, Dahl\u00f6f B, Devereux RB. Left atrial size and risk of major cardiovascular events during antihypertensive treatment. Hypertension. 2007;49(2):311\u20136.","journal-title":"Hypertension"},{"issue":"4","key":"632_CR11","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1161\/HYPERTENSIONAHA.107.107474","volume":"51","author":"E Gerdts","year":"2008","unstructured":"Gerdts E, Okin PM, de Simone G, Cramariuc D, Wachtell K, Boman K, Devereux RB. Gender differences in left ventricular structure and function during antihypertensive treatment. Hypertension. 2008;51(4):1109\u201314.","journal-title":"Hypertension"},{"key":"632_CR12","doi-asserted-by":"crossref","unstructured":"Gerdts E, Oikarinen L, Palmieri V, Otterstad JE, Wachtell K, Boman K, Dahl\u00f6f B, Devereux RB, Study LIFER in H (LIFE). Correlates of left atrial size in hypertensive patients with left ventricular hypertrophy. Hypertension. 2002;39(3):739\u201343.","DOI":"10.1161\/hy0302.105683"},{"key":"632_CR13","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1016\/j.ijcard.2017.12.086","volume":"258","author":"E Gerdts","year":"2018","unstructured":"Gerdts E, Izzo R, Mancusi C, Losi MA, Manzi MV, Canciello G, Luca ND, Trimarco B, de Simone G. Left ventricular hypertrophy offsets the sex difference in cardiovascular risk (the Campania Salute Network). Int J Cardiol. 2018;258:257\u201361.","journal-title":"Int J Cardiol"},{"issue":"1","key":"632_CR14","doi-asserted-by":"publisher","first-page":"136","DOI":"10.1161\/HYPERTENSIONAHA.116.08158","volume":"69","author":"R Izzo","year":"2017","unstructured":"Izzo R, Losi MA, Stabile E, L\u00f6nnebakken MT, Canciello G, Esposito G, Barbato E, Luca ND, Trimarco B, de Simone G. Development of left ventricular hypertrophy in treated hypertensive outpatients. Hypertension. 2017;69(1):136\u201342.","journal-title":"Hypertension"},{"issue":"3","key":"632_CR15","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s40292-018-0265-0","volume":"25","author":"ML Muiesan","year":"2018","unstructured":"Muiesan ML, Paini A, Aggiusti C, Bertacchini F, Rosei CA, Salvetti M. Hypertension and organ damage in women. High Blood Press Cardiovasc Prev. 2018;25(3):245\u201352.","journal-title":"High Blood Press Cardiovasc Prev."},{"key":"632_CR16","doi-asserted-by":"crossref","unstructured":"Granger BB, Swedberg K, Ekman I, Granger CB, Olofsson B, McMurray JJ, Yusuf S, Michelson EL, Pfeffer MA, investigators for the C. Adherence to candesartan and placebo and outcomes in chronic heart failure in the CHARM programme: double-blind, randomised, controlled clinical trial. Lancet. 2005;366(9502):2005\u201311.","DOI":"10.1016\/S0140-6736(05)67760-4"},{"issue":"3","key":"632_CR17","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1161\/HYPERTENSIONAHA.121.17514","volume":"78","author":"OU Bergland","year":"2021","unstructured":"Bergland OU, Halvorsen LV, S\u00f8raas CL, Hj\u00f8rnholm U, Kj\u00e6r VN, Rognstad S, Brobak KM, Aune A, Olsen E, Fauchald YM, Heimark S, Thorstensen CW, Liest\u00f8l K, Solbu MD, Gerdts E, Mo R, Rostrup M, Kjeldsen SE, H\u00f8ieggen A, Opdal MS, Larstorp ACK, Elmula FEMF. Detection of nonadherence to antihypertensive treatment by measurements of serum drug concentrations. Hypertension. 2021;78(3):617\u201328.","journal-title":"Hypertension"},{"key":"632_CR18","doi-asserted-by":"crossref","unstructured":"Levey AS, Jong PE de, Coresh J, Nahas ME, Astor BC, Matsushita K, Gansevoort RT, Kasiske BL, Eckardt KU. The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report. Kidney Int. 2011;80(1):17\u201328.","DOI":"10.1038\/ki.2010.483"},{"key":"632_CR19","doi-asserted-by":"crossref","unstructured":"Levey AS, Stevens LA, Schmid CH, Zhang YL, Castro AF, Feldman HI, Kusek JW, Eggers P, Lente FV, Greene T, Coresh J, Collaboration) CE (Chronic KDE. A New Equation to Estimate Glomerular Filtration Rate. Ann Intern Med. 2009;150(9):604.","DOI":"10.7326\/0003-4819-150-9-200905050-00006"},{"issue":"10","key":"632_CR20","doi-asserted-by":"publisher","first-page":"1919","DOI":"10.1097\/HJH.0000000000002510","volume":"38","author":"P Mulatero","year":"2020","unstructured":"Mulatero P, Monticone S, Deinum J, Amar L, Prejbisz A, Zennaro MC, Beuschlein F, Rossi GP, Nishikawa T, Morganti A, Seccia TM, Lin YH, Fallo F, Widimsky J. Genetics, prevalence, screening and confirmation of primary aldosteronism: a position statement and consensus of the Working Group on Endocrine Hypertension of The European Society of Hypertension. J Hypertens. 2020;38(10):1919\u201328.","journal-title":"J Hypertens"},{"key":"632_CR21","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2022.114908","volume":"219","author":"CW Thorstensen","year":"2022","unstructured":"Thorstensen CW, Clasen PE, Rognstad S, Haldsrud R, F\u00f8reid S, Helstr\u00f8m T, Bergland OU, Halvorsen LV, Aune A, Olsen E, Brobak KM, H\u00f8ieggen A, Gustavsen I, Larstorp ACK, S\u00f8raas CL, Opdal MS. Development of UHPLC-MS\/MS methods to quantify 25 antihypertensive drugs in serum in a cohort of patients treated for hypertension. J Pharmaceut Biomed. 2022;219: 114908.","journal-title":"J Pharmaceut Biomed."},{"issue":"1","key":"632_CR22","doi-asserted-by":"publisher","first-page":"116","DOI":"10.1097\/FTD.0000000000000806","volume":"43","author":"S Rognstad","year":"2021","unstructured":"Rognstad S, S\u00f8raas CL, Bergland OU, H\u00f8ieggen A, Str\u00f8mmen M, Helland A, Opdal MS. Establishing serum reference ranges for antihypertensive drugs. Ther Drug Monit. 2021;43(1):116\u201325.","journal-title":"Ther Drug Monit"},{"issue":"3","key":"632_CR23","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1093\/ehjci\/jev014","volume":"16","author":"RM Lang","year":"2015","unstructured":"Lang RM, Badano LP, Mor-Avi V, Afilalo J, Armstrong A, Ernande L, Flachskampf FA, Foster E, Goldstein SA, Kuznetsova T, Lancellotti P, Muraru D, Picard MH, Rietzschel ER, Rudski L, Spencer KT, Tsang W, Voigt JU. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. Eur Heart J Cardiovasc Imaging. 2015;16(3):233\u201371.","journal-title":"Eur Heart J Cardiovasc Imaging"},{"issue":"1","key":"632_CR24","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1186\/1476-7120-9-26","volume":"9","author":"M Galderisi","year":"2011","unstructured":"Galderisi M, Nistri S, Mondillo S, Losi MA, Innelli P, Mele D, Muraru D, D\u2019Andrea A, Ballo P, Sgalambro A, Esposito R, Marti G, Santoro A, Agricola E, Badano LP, Marchioli R, Filardi PP, Mercuro G, Marino PN. Methodological approach for the assessment of ultrasound reproducibility of cardiac structure and function: a proposal of the study group of Echocardiography of the Italian Society of Cardiology (Ultra Cardia SIC) Part I. Cardiovasc Ultrasoun. 2011;9(1):26.","journal-title":"Cardiovasc Ultrasoun"},{"issue":"3","key":"632_CR25","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/S0002-9149(00)01362-X","volume":"87","author":"EC Jones","year":"2001","unstructured":"Jones EC, Devereux RB, Roman MJ, Liu JE, Fishman D, Lee ET, Welty TK, Fabsitz RR, Howard BV. Prevalence and correlates of mitral regurgitation in a population-based sample (the Strong Heart Study)\u2217\u2217The views expressed in this study are those of the authors and do not necessarily reflect those of the Indian Health Service. Am J Cardiol. 2001;87(3):298\u2013304.","journal-title":"Am J Cardiol"},{"issue":"6","key":"632_CR26","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1093\/ejechocard\/jen155","volume":"9","author":"E Gerdts","year":"2008","unstructured":"Gerdts E, Cramariuc D, de Simone G, Wachtell K, Dahl\u00f6f B, Devereux RB. Impact of left ventricular geometry on prognosis in hypertensive patients with left ventricular hypertrophy (the LIFE study). Eur J Echocardiogr. 2008;9(6):809\u201315.","journal-title":"Eur J Echocardiogr"},{"issue":"5","key":"632_CR27","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1161\/HYPERTENSIONAHA.114.03246","volume":"63","author":"FEMF Elmula","year":"2014","unstructured":"Elmula FEMF, Hoffmann P, Larstorp AC, Fossum E, Brekke M, Kjeldsen SE, Gj\u00f8nn\u00e6ss E, Hj\u00f8rnholm U, Kj\u00e6r VN, Rostrup M, Os I, Stenehjem A, H\u00f8ieggen A. Adjusted drug treatment is superior to renal sympathetic denervation in patients with true treatment-resistant hypertension. Hypertension. 2014;63(5):991\u20139.","journal-title":"Hypertension"},{"issue":"11","key":"632_CR28","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1038\/s41591-019-0643-8","volume":"25","author":"E Gerdts","year":"2019","unstructured":"Gerdts E, Regitz-Zagrosek V. Sex differences in cardiometabolic disorders. Nat Med. 2019;25(11):1657\u201366.","journal-title":"Nat Med"},{"key":"632_CR29","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.ijcard.2017.06.045","volume":"244","author":"C Mancusi","year":"2017","unstructured":"Mancusi C, Gerdts E, Losi MA, D\u2019Amato A, Manzi MV, Canciello G, Trimarco V, Luca ND, de Simone G, Izzo R. Differential effect of obesity on prevalence of cardiac and carotid target organ damage in hypertension (the Campania Salute Network). Int J Cardiol. 2017;244:260\u20134.","journal-title":"Int J Cardiol"},{"key":"632_CR30","doi-asserted-by":"crossref","unstructured":"L\u00f8nnebakken MT, Izzo R, Mancusi C, Gerdts E, Losi MA, Canciello G, Giugliano G, Luca ND, Trimarco B, Simone G de. Left ventricular hypertrophy regression during antihypertensive treatment in an outpatient clinic (the campania salute network). J Am Heart Assoc. 2017;6(3).","DOI":"10.1161\/JAHA.116.004152"},{"issue":"4","key":"632_CR31","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1016\/0735-1097(88)90467-6","volume":"12","author":"IW Hammond","year":"1988","unstructured":"Hammond IW, Devereux RB, Alderman MH, Laragh JH. Relation of blood pressure and body build to left ventricular mass in normotensive and hypertensive employed adults. J Am Coll Cardiol. 1988;12(4):996\u20131004.","journal-title":"J Am Coll Cardiol"},{"key":"632_CR32","doi-asserted-by":"crossref","unstructured":"Hendriks T, Said MA, Janssen LMA, Ende MY van der, Veldhuisen DJ van, Verweij N, Harst P van der. Effect of systolic blood pressure on left ventricular structure and function. Hypertension. 74(4):826\u201332.","DOI":"10.1161\/HYPERTENSIONAHA.119.12679"},{"issue":"4","key":"632_CR33","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1080\/08037051.2021.1904775","volume":"30","author":"A Aune","year":"2021","unstructured":"Aune A, Kokorina M, Grytaas MA, Midtb\u00f8 H, L\u00f8v\u00e5s K, Gerdts E. Preclinical cardiac disease in women and men with primary aldosteronism. Blood Press. 2021;30(4):1\u20137.","journal-title":"Blood Press"},{"issue":"2","key":"632_CR34","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1067\/mhj.2002.119895","volume":"143","author":"K Wachtell","year":"2002","unstructured":"Wachtell K, Palmieri V, Olsen MH, Bella JN, Aalto T, Dahl\u00f6f B, Gerdts E, Wright JT, Papademetriou V, Mogensen CE, Borch-Johnsen K, Ibsen H, Devereux RB. Urine albumin\/creatinine ratio and echocardiographic left ventricular structure and function in hypertensive patients with electrocardiographic left ventricular hypertrophy: the LIFE study. Am Heart J. 2002;143(2):319\u201326.","journal-title":"Am Heart J"},{"issue":"6","key":"632_CR35","doi-asserted-by":"publisher","first-page":"897","DOI":"10.1016\/S0002-9149(98)01064-9","volume":"83","author":"JP Singh","year":"1999","unstructured":"Singh JP, Evans JC, Levy D, Larson MG, Freed LA, Fuller DL, Lehman B, Benjamin EJ. Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study). Am J Cardiol. 1999;83(6):897\u2013902.","journal-title":"Am J Cardiol"},{"issue":"1","key":"632_CR36","doi-asserted-by":"publisher","DOI":"10.1136\/openhrt-2022-002180","volume":"10","author":"A Moonen","year":"2023","unstructured":"Moonen A, Ng MKC, Playford D, Strange G, Scalia GM, Celermajer DS. Atrial functional mitral regurgitation: prevalence, characteristics and outcomes from the National Echo Database of Australia. Open Hear. 2023;10(1): e002180.","journal-title":"Open Hear."},{"issue":"1","key":"632_CR37","doi-asserted-by":"publisher","first-page":"10","DOI":"10.7326\/M20-0065","volume":"173","author":"JM Brown","year":"2020","unstructured":"Brown JM, Siddiqui M, Calhoun DA, Carey RM, Hopkins PN, Williams GH, Vaidya A. The unrecognized prevalence of primary aldosteronism: a cross-sectional study. Ann Intern Med. 2020;173(1):10\u201320.","journal-title":"Ann Intern Med"},{"issue":"12","key":"632_CR38","doi-asserted-by":"publisher","first-page":"3771","DOI":"10.1210\/clinem\/dgaa606","volume":"105","author":"A Vaidya","year":"2020","unstructured":"Vaidya A, Carey RM. Evolution of the primary aldosteronism syndrome: updating the approach. J Clin Endocrinol Metabolism. 2020;105(12):3771\u201383.","journal-title":"J Clin Endocrinol Metabolism."},{"issue":"03","key":"632_CR39","first-page":"170","volume":"44","author":"M Stowasser","year":"2011","unstructured":"Stowasser M, Ahmed A, Pimenta E, Taylor P, Gordon R. Factors AFFECTING THE ALDOSTERONE\/RENIN RATIO. Horm Metab Res. 2011;44(03):170\u20136.","journal-title":"Horm Metab Res"},{"issue":"12","key":"632_CR40","doi-asserted-by":"publisher","first-page":"967","DOI":"10.1093\/ajh\/hpac079","volume":"35","author":"A Vaidya","year":"2022","unstructured":"Vaidya A, Hundemer GL, Nanba K, Parksook WW, Brown JM. Primary aldosteronism: state-of-the-art review. Am J Hypertens. 2022;35(12):967\u201388.","journal-title":"Am J Hypertens"},{"issue":"11","key":"632_CR41","doi-asserted-by":"publisher","first-page":"3175","DOI":"10.1210\/clinem\/dgac460","volume":"107","author":"P Mulatero","year":"2022","unstructured":"Mulatero P, Bertello C, Veglio F, Monticone S. Approach to the patient on antihypertensive therapy: screen for primary aldosteronism. J Clin Endocrinol Metab. 2022;107(11):3175\u201381.","journal-title":"J Clin Endocrinol Metab"}],"container-title":["High Blood Pressure & Cardiovascular Prevention"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40292-024-00632-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40292-024-00632-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40292-024-00632-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T05:10:18Z","timestamp":1713935418000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40292-024-00632-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3,26]]},"references-count":41,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,3]]}},"alternative-id":["632"],"URL":"https:\/\/doi.org\/10.1007\/s40292-024-00632-6","relation":{},"ISSN":["1179-1985"],"issn-type":[{"value":"1179-1985","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,3,26]]},"assertion":[{"value":"14 January 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 March 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 March 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors report no disclosures.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Disclosures"}},{"value":"The Authors have no conflict of interest.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interests"}},{"value":"Open access funding provided by University of Bergen (incl Haukeland University Hospital). Grants from the Research Council of Norway (Grant number 273563), the South East Norwegian Regional Health Authorities (Grant number 2017014), and the Western Norway Regional Health Authorities (Grant number F-12150).","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The data may be made available by the authors upon reasonable request.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Data Availability"}}]}}